EFL075 - Methimazole Titration and Initial Disease Severity in Graves Disease

<p>For our 75th episode, we review a forthcoming Journal of Clinical Endocrinology &amp; Metabolism study examining how initial disease severity in Graves’ disease may influence methimazole titration. This retrospective longitudinal cohort study includes 152 patients treated at a single center, offering insight into real-world dosing and monitoring practices.</p><p>Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, is joined by new regular contributor Jonea Lim, MD, from the University of Oklahoma, along with guest expert Elizabeth Pearce, MD, from Boston University, to discuss <a href="https://doi.org/10.1210/clinem/dgag134" rel="noopener noreferrer" target="_blank" style="color: rgb(0, 45, 114); background-color: transparent;"><strong>"Initial disease severity and methimazole titration for Graves' disease: a retrospective longitudinal cohort study" </strong></a>and its implications for clinical management.</p>